Retinoid 9cUAB30

DRUG4 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Breast Ductal Carcinoma In SituEarly Stage Breast Carcinoma

Phase 1

Study of 9cUAB30 in Healthy Participants

CompletedNCT00896974

National Cancer Institute (NCI)No Evidence of Disease

Start: 2008-08-31End: 2010-03-31Updated: 2015-06-18

Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers

TerminatedNCT01336387

National Cancer Institute (NCI)Healthy, no Evidence of Disease

Start: 2011-10-31End: 2012-09-30Updated: 2014-10-09

Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers

CompletedNCT01935960

National Cancer Institute (NCI)Healthy Subject

Start: 2013-08-31Updated: 2016-12-23

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

TerminatedNCT02876640

National Cancer Institute (NCI)Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 +6

Start: 2018-03-16End: 2022-06-03Updated: 2024-06-18